Clinical trial
Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to…
NCT00219453 · PATH, Other · Completed
Key facts
| NCT number | NCT00219453 |
|---|---|
| Title | Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination |
| Official title | A Pilot Safety Study to Determine the Presence of Hepatitis B Virus in Downstream Injection Samples Using the HSI-500 Jet Injector With Protector Cap |
| Lead sponsor | PATH, Other |
| Collaborators | Bill and Melinda Gates Foundation |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Virus Diseases, Hepatitis B |
| Intervention type | Device |
| Interventions | Jet Injector with Protector Cap (HSI-500) |
| Enrollment | 17 |
| Start date | Oct 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 19, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: